SEC Form 4 · accession 0001493152-15-002563
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William B Horne
Officer — Chief Financial Officer
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 3:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420030
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 17, 2015 | A | 200,000 | $0.08 | A | 265,769 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $0.30 | Jun 17, 2015 | A | 200,000 | A | — | Jun 17, 2020 | Common Stock | 200,000 | 350,000 | D |
Explanation of responses
- F1The options were issued pursuant to the Company's 2011 Stock Incentive Plan. Options to purchase 200,000 shares shall vest 100,000 on June 17, 2016 and 100,000 on June 17, 2017.